$165.11+67.68% · 3M
Moving avg
1W+1.18%
1M+4.24%
3M+67.68%
6M+53.48%
YTD+62.29%
1Y+199.66%
3Y+361.07%
5Y+55.91%
52-week range
$40.3593% of range$174.08
Company health
Value0/6
Growth3/6
Profitability2/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (18427%)
- Revenue compounding 50% a year
Risks
- Currently unprofitable
- Burning free cash flow
- More volatile than the market (beta 1.6)
Key statistics
Valuation
Market cap
$22.16B
Enterprise value
$20.91B
P/E ratio (TTM)
-44.92x
P/S ratio (TTM)
18.69x
EV/EBITDA
-53.48x
Per share & returns
EPS (TTM)
-$3.30
Dividend yield
0.00%
Beta (1Y)
1.59
30-day change
+4.24%
Trading
Volume (24h)
1.22M
Previous close
$165.09
Shares outstanding
134.20M
About Guardant Health, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
GH
Guardant Health, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ (United States) and trade under the ticker GH.
Frequently asked questions
What is Guardant Health, Inc.'s market cap?
Guardant Health, Inc. (GH) has a market capitalization of $22.16B.
What sector is Guardant Health, Inc. in?
Guardant Health, Inc. operates in the Healthcare sector, Medical - Diagnostics & Research industry.
What exchange does GH trade on?
GH trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap